41 Cathepsin D Expression in Pancreatic Ductal Adenocarcinoma (PDAC) Cells Increases Proliferation and Reduces Survival of Pancreatic Cancer Patients
Ujjwal Mukund Mahajan(Medi-Caps University), Julia Mayerle(LMU Klinikum), William Greenhalf(University of Liverpool), Theresa Schwaiger(University of Graz), Markus W. Büchler(Heidelberg University), John P. Neoptolemos(University of Liverpool), Christopher Halloran(University of Liverpool), Markus M. Lerch(Ludwig-Maximilians-Universität München), Eithne Costello(University of Liverpool), Enno Langhoff, Frank Ulrich Weiß(Universitätsmedizin Greifswald)
Cited by 0
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k